After removing the IVs associated with HMG CoA reductase inhibitors, the association between LDL-C and ALS was absent (OR = 1.036, 95% CI = 0.949–1.131, p = 0.432). The gene discussed is HMGCR; the disease is amyotrophic lateral sclerosis.